Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Reviews

Physical Activity and Risk of Lymphoma: A Meta-Analysis

Nele V.H. Vermaete, Pascal Wolter, Gregor E.G. Verhoef, Boudewijn J. Kollen, Gert Kwakkel, Leen Schepers and Rik Gosselink
Nele V.H. Vermaete
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pascal Wolter
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregor E.G. Verhoef
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boudewijn J. Kollen
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert Kwakkel
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leen Schepers
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rik Gosselink
1Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven Department of Rehabilitation Sciences; 2Department of General Medical Oncology; 3Department of Hematology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium; 4Department of General Practice—University of Groningen, University Medical Center Groningen; and 5VU University Medical Centre, Department of Rehabilitation Medicine, Research Institute MOVE, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-0182 Published July 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Physical activity has a protective effect on some types of cancer. The aim of the present meta-analysis was to explore the literature on the association between physical activity and risk of lymphoma.

Methods: A meta-analysis was conducted for cohort and case–control studies examining the association between self-reported physical activity and risk of lymphoma. Depending on statistical heterogeneity, a random or fixed effects model was used to estimate the summary OR and corresponding 95% confidence interval (CI).

Results: Seven case–control studies and 5 cohort studies were included. When data from both study designs were combined, no significant influence of physical activity on risk of lymphoma was found (pooled OR = 0.90; 95% CI: 0.79–1.02; P = 0.10). Subgroup analysis revealed a significant protective influence of physical activity on risk of lymphoma in case–control studies (pooled OR = 0.81; 95% CI: 0.68–0.96; P = 0.02). In contrast, cohort studies, which have a higher level of evidence than case–control studies, confirm the results of the primary meta-analysis (pooled OR = 1.02; 95% CI: 0.88–1.19; P = 0.76). A subsequent subgroup analysis found no significant differences between results for Hodgkin lymphoma and non-Hodgkin lymphoma (χ2 = 0.16; P = 0.69), nor between results for recreational and occupational activities (χ2 = 1.01; P = 0.31).

Conclusions: Epidemiologic research indicates no significant influence of physical activity on risk of lymphoma.

Impact: Future research should examine the association between sedentary behavior and risk of lymphoma and investigate the dose–response and timing effect of physical activity on risk of lymphoma. Cancer Epidemiol Biomarkers Prev; 22(7); 1173–84. ©2013 AACR.

Introduction

Cancer is a leading cause of disease and death worldwide. In total, 7.6 million cancer deaths occurred in 2008, accounting for about 13% of all deaths (1, 2). Lymphomas are part of the hematologic cancers, arising in the lymph nodes and tissues of the body's immune system and comprising several subtypes with varied biologic and clinical features (3). The main subdivision is made between Hodgkin lymphoma and non-Hodgkin lymphoma. In 2008, about 67.000 new Hodgkin lymphoma cases and 355.000 new non-Hodgkin lymphoma cases occurred worldwide, accounting for 0.5 and 2.8% of all new cancer cases, respectively. Similar percentages were found for mortality in Hodgkin lymphoma and non-Hodgkin lymphoma worldwide in 2008: 0.4% of all cancer deaths were attributed to Hodgkin lymphoma and 2.5% to non-Hodgkin lymphoma (2, 4). In general, the incidence of lymphoma is rising in the last decades (5–7). As a consequence, more emphasis is given to implement evidence-based strategies for lymphoma prevention. To set up strategies for lymphoma prevention, understanding the modifiable risk factors for lymphoma is critical. Physical inactivity has recently received much attention as modifiable risk factor. It is well known that physical activity is effective in preventing and modifying chronic diseases, such as osteoporosis (8), obesity (9), type II diabetes (9, 10), dementia (11), hypertension (12), metabolic syndrome (13), cardiovascular (14), and respiratory diseases (15). Since the last decades, evidence is growing that physical activity also reduces the risk of some types of cancer. Evidence is convincing for a positive influence of physical activity on risk of colon (16), breast (17, 18), and endometrial cancer (19). Inconsistent evidence is found for lung (20), prostate (21), and ovarian cancer (22) with at least one-third of the studies indicating a protective effect of physical activity on risk (23). For breast, ovarian, and lung cancer, the effect seems stronger for recreational than occupational physical activity (20, 22, 24). Recently, studies were conducted to examine the association between physical activity and lymphoma. The aim of the present meta-analysis was to explore the literature on the relationship between physical activity and the risk of lymphoma.

Materials and Methods

Search strategy and selection criteria

A search was conducted by one reviewer (N. Vermaete) in PubMed, Cochrane, PEDro, Embase, CINAHL, and Web of science up to 8 January 2013. In PubMed, Cochrane, Embase, CINAHL, and Web of Science, the following combination of key words was used: “(lymphoma OR Hodgkin) and risk (“physical activity” OR “physical fitness” OR exercise OR “cardiorespiratory fitness”)”. In PubMed, no limits were used. “Title” was used as field limit in Cochrane, Embase, and Web of Science, whereas “abstract” was used as field limit in CINAHL. In PEDro, only “lymphoma” was used as key word, without limits. Titles and abstracts were screened on content. For relevant articles, the full text was used. The reference lists of all selected articles were also screened for additional papers. No restrictions in date of publication, language, and group size were used. Furthermore, no restrictions in methods to assess physical activity were used. Articles with participants younger than 18 or childhood cancer were excluded. Articles were included if they met following criteria: (i) case–control or cohort study, (ii) reporting a risk estimate and corresponding SE of the relationship between recreational, occupational, or overall physical activity and lymphoma.

Data extraction and assessment of study quality

For each article, information was extracted on the study design, sample size, number of cases, gender, study region, age, physical activity domain, assessment of physical activity, timing in life of physical activity, definition of highest/lowest activity level, and adjustment for confounding factors. Methodologic quality of each study was assessed using a quality score system that was partly adopted from Monninkhof and colleagues (Supplementary Table; ref. 18). Item 12 (considering changes over time) and item 16 (influence of ductal carcinoma in situ) from the original quality score system were excluded, because these items were not relevant for this meta-analysis. Quality assessment was conducted independently by 2 reviewers (N. Vermaete and L. Schepers). An interrater reliability analysis using the Kappa statistic was conducted in SPSS (version 19) to determine consistency among raters. Disagreements were resolved by discussion. An independent samples t test was conducted in SPSS (version 19) to examine the difference in quality score between case–control and prospective cohort studies.

Analysis

The summary odds ratio (OR) and corresponding 95% confidence interval (CI) was estimated to assess the association between physical activity and risk of lymphoma, comparing highest activity level to lowest activity level. For studies reporting an OR with highest activity level as reference instead of lowest activity level, the inverse of the reported OR was used. The most adjusted risk estimate reported in each study was used. If effect estimates for physical activity were reported for more than one-life period, the most recent data were used, as most studies reported recent physical activity. If a study reported risk estimates for men and women separately, both results were included in the analysis. Statistical heterogeneity between studies was determined by using the Q and I2 statistics (25). For the Q-statistic, a P-value below 0.05 indicates statistical heterogeneity. For the I2 statistic, Higgins and colleagues tentatively assigned adjectives of low, moderate, and high to I2 values of 25%, 50%, and 75% (25). In this meta-analysis, statistical heterogeneity was defined as a P-value below 0.05 for the Q-statistics or an I2 value above 50%. When there was a discrepancy in the result for heterogeneity between both tests, the result of the I2 value was chosen. Depending on statistical heterogeneity, a random or fixed effects model was used to estimate the summary OR and corresponding 95% CI. As randomized controlled trials are not available for this research question, it is inevitable to rely on study designs with less evidential value. In the primary analysis, case–control and prospective cohort studies were combined. The reported risk estimates for the association between total physical activity and risk of lymphoma were used in the primary analysis. For studies reporting only results for recreational or occupational physical activity, these results were included in the analysis. For studies reporting separate results for occupational and recreational physical activity, but no result for total physical activity, the results for recreational physical activity were used. It has been suggested that recreational physical activity is the major modifiable component of energy expenditure (26). Three subgroup analyses were conducted: one for study design (case–control and prospective cohort studies), one for type of lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma) and one for physical activity domain (recreational and occupational physical activity). All analyses were conducted with Review Manager version 5 (27)

Results

Study selection

The flowchart of the selection of articles is provided in Fig. 1. The literature search resulted in a total of 148 references. After reading of title, abstract, and eventually full text, 10 studies were retained. After screening of the reference lists of the selected articles, 2 more articles were included (28, 29). This resulted in a total of 12 selected publications.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Flow chart of selection.

Study characteristics

The main characteristics of the 7 case–control studies and the 5 prospective cohort studies are summarized in Table 1. The 7 case–control studies included a total of 5,229 non-Hodgkin lymphoma cases, 366 Hodgkin lymphoma cases, and 26,403 control subjects (28, 30–35). In the 5 prospective cohort studies, a total of 5,858 non-Hodgkin lymphoma cases and 58 Hodgkin lymphoma cases were identified among a total of 3,154,781 subjects (29, 36–39). Two studies involved only men (28, 34) and 3 involved only women (33, 37, 39). Seven studies involved both men and women with 5 studies reporting gender-specific results (30, 32, 35, 36, 38) and 2 reporting results for both genders combined (29, 31). Eight studies reported on recreational physical activity (31–34, 36–39), 5 studies on occupational physical activity (28, 30, 31, 34, 36), and 4 studies on total physical activity (29, 34–36). All studies used a self-reported instrument to assess physical activity. Considerable variation between studies was found with respect to the instrument used to assess physical activity, the definition of “highest activity” and “lowest activity” level and the adjustment for confounding factors.

View this table:
  • View inline
  • View popup
Table 1.

Characteristics of included studies

Quality score

The total quality score, as percentage of the maximal score for cohort and case–control studies combined, ranged between 42% and 82% (median 62%). For the 5 cohort studies, the quality score ranged between 69% and 82% (median 75%), which is statistically significantly higher (P = 0.001) than the quality score of the 7 case–control studies, with scores ranging between 42% and 63% (median 57%; Table 2). Cohen Kappa for interrater reliability equaled 0.823 (95% CI: 0.762–0.884; P < 0.01).

View this table:
  • View inline
  • View popup
Table 2.

Quality score of included studies

Primary meta-analysis

The 5 cohort studies and the 7 case–control studies were included in the primary meta-analysis. Five studies reported a risk estimate for men and women separately (30, 32, 35, 36, 38), 2 studies reported results for Hodgkin lymphoma and non-Hodgkin lymphoma separately (29, 34), and 1 study reported results for 2 separate age groups (33). Consequently, 20 studied groups were included in the primary meta-analysis. The Q-statistic showed significant heterogeneity between study results (P < 0.01; I2 = 59%). The random effects meta-analysis found no significant influence of physical activity on risk of lymphoma (pooled OR = 0.90; 95% CI = 0.79–1.02; P = 0.10, Fig. 2 and Table 3).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Primary meta-analysis: random-effects meta-analysis of the influence of physical activity on risk lymphoma. Abbreviations: F, women; M, men; occ, occupational; recr, recreational.

View this table:
  • View inline
  • View popup
Table 3.

Summary of results from the primary random-effects meta-analysis and the subgroup random-effects meta-analyses

Subgroup meta-analyses

Table 3 and Supplementary Fig. S1 show the sensitivity analysis of study design (prospective cohort studies versus case–control studies). The summary risk estimate derived from the cohort studies showed no significant influence of physical activity on risk of lymphoma (OR = 1.02; 95% CI: 0.88–1.19; P = 0.76). In contrast, the results from the fixed effects meta-analysis in the case–control studies showed a significant protective influence of physical activity on risk of lymphoma (OR = 0.81; 95% CI: 0.72–0.91; P = 0.0006).

Table 3 and Supplementary Fig. S2 show the sensitivity analysis of type of lymphoma (Hodgkin lymphoma vs. non-Hodgkin lymphoma). The random effects of meta-analysis showed no significant influence of physical activity on risk of Hodgkin lymphoma or on risk of non-Hodgkin lymphoma (OR = 0.82; 95% CI: 0.47–1.42; P = 0.47 and OR = 0.92; 95% CI: 0.81–1.04; P = 0.19, respectively).

Table 3 and Supplementary Fig. S3 show the sensitivity analysis of physical activity domain (recreational physical activity vs. occupational physical activity). The meta-analysis showed no significant influence of recreational (random effects model) nor of occupational physical activity (fixed effects model) on risk of lymphoma (OR = 0.86; 95% CI: 0.73–1.02; P = 0.08 and OR = 0.98; 95% CI: 0.80–1.21; P = 0.88, respectively).

Discussion

The aim of the present meta-analysis was to explore the literature on the relationship between physical activity and risk of lymphoma. Seven case–control studies and 5 cohort studies were included. The primary meta-analysis found no significant effect of physical activity on risk of lymphoma. Subgroup analysis for study design showed no significant influence of physical activity on risk of lymphoma in cohort studies and a significant risk reduction in case–control studies. However, the level of evidence generated by case–control studies is considerably less than that by prospective cohort studies, according to the Centre for Evidence-Based Medicine (40). Bias is less of concern in prospective cohort studies than in case–control studies, because classification of exposure is made independently of knowledge about the subject's disease status (41). As a consequence, the outcomes of prospective cohort studies should take priority in determining the relevance of our study outcomes. The results of the cohort studies confirm the results of the primary meta-analysis. Subgroup analysis for lymphoma type revealed no significant differences between results found in Hodgkin lymphoma and results found in non-Hodgkin lymphoma. Similarly, subgroup analysis for the physical activity domain also revealed no significant differences between recreational and occupational activity. This conclusion was also reached in meta-analyses examining the association between physical activity and risk of endometrial (42), prostate (21), and colorectal cancer risk (43, 44).

In general, reporting of observational biomedical research is often inadequate. Therefore, the Strengthening of Reporting of Observational Studies in Epidemiology (STROBE) statement has been established (45). The quality score system used in this meta-analysis is consistent with these guidelines, although it does not cover all 22 items of the STROBE statement. The methodologic quality of the included studies varied. Inherent to the study design, the methodologic quality of the cohort studies was higher than that in the case–control studies. Some studies were of low quality, especially regarding the assessment of physical activity. Although a positive evolution could be expected as the establishment of the STROBE statement, no clear evolution in methodological quality was observed over time. Another limitation in this meta-analysis is the methodologic and statistical heterogeneity between studies. As a consequence, the conclusion of the present meta-analysis indicating that physical activity has no effect on the risk of lymphoma, should be interpreted with caution.

Assessment of physical activity

Several methods exist to assess physical activity, with remarkable differences in validity and reliability. The two most widely used methods are objective assessment by an accelerometer and subjective self-reported assessment by a self-reported questionnaire (46). Accelerometers are more accurate than self-reported instruments, give information on the total amount, intensity, duration, and frequency of physical activity and are sufficiently sensitive to detect small movements. Disadvantages of accelerometers are the higher cost and need for additional hardware/software and technical expertise (46, 47). All 12 studies included in this meta-analysis used a self-reported instrument. Advantages of this method are that questionnaires are inexpensive, relatively reliable, and applicable in large populations (47). There are, however, also considerable limitations, including recall error, over-reporting, lack of accuracy, specific focus on activities with moderate-to-vigorous intensity (46, 47), and thus a wide range of reliability and validity (48). Half of the included studies in this meta-analysis used global assessments of physical activity, without specifically considering the frequency, duration, and intensity of physical activity (28–30, 33, 34, 39). Two studies administered an investigator-designed instrument (32, 39), 2 studies used an existing classification scheme to categorize occupational activity (28, 30, 49–52), 1 study used an instrument used in a previous study (33, 53), 1 study used 4 questions derived from development work undertaken in The Netherlands (36), and in 6 studies the origin of the self-reported instrument was not reported (29, 31, 34, 35, 37, 38). The “total physical activity” index used in the study of Van Veldhoven and colleagues (36) was shown to be sufficient for ranking or classifying subjects in terms of their physical activity in large-epidemiologic studies (54) but no information was reported on the validity of the assessment of recreational and occupational activity. The validity of the self-reported instruments in the other included studies was unknown.

Level of physical activity

Remarkable differences were found in the definitions of the “highest activity level.” For example, in the study of Van Veldhoven and colleagues (36), the highest activity level was defined as 45.74 MET-hours/week or more, whereas the highest activity level was defined as 17.5 MET-hours/week or more in other 2 studies (37, 38). This discrepancy in definition hampered pooling of data and thus the interpretation of the results from different studies. Conversion of the reported physical activity levels in the different studies into 2 categories using a fixed cut-off value was aimed for. The most obvious cut-off value would correspond with the public health guidelines for physical activity defined by the American College of Sports Medicine as engaging in 30 or more minutes per day of at least moderate physical activity on 5 or more days of the week, or more than 150 minutes a week (55). However, it was not possible to convert the results of each study into these dichotomous physical activity categories in an unambiguous way. Therefore, the influence of the level of physical activity on the risk of lymphoma could not be studied in more detail in the present meta-analysis. However, 8 of the included studies examined the presence of dose–response effect of physical activity on risk of lymphoma. Four of the 5 cohort studies (29, 37–39) and 4 of the 7 case–control studies (30–32, 35) reported a test of trend, with 1 cohort study (37) and 3 case–control studies (31, 32, 35) reporting a significant trend. For example, Kelly and colleagues found a significant trend of physical activity on non-Hodgkin lymphoma risk among women (Ptrend = 0.039), but not among men (Ptrend = 0.15; ref. 35). In the literature, convincing evidence was found for a significant dose–response effect of decreasing cancer risk with increasing activity levels for colon cancer and breast cancer (23, 56, 57).

In addition, Zahm and colleagues found no significant association between occupational sitting time (sedentary behavior) and non-Hodgkin lymphoma among men and women (30). Teras and colleagues found no significant association between leisure-time sitting and non-Hodgkin lymphoma risk in men, whereas a significant positive association was found between leisure-time sitting and risk of non-Hodgkin lymphoma in women (38). In the literature, sedentary behavior has been shown to be associated with a higher risk of ovarian, endometrial, and colorectal cancer (23, 42, 58).

Timing of physical activity

Evidence for a timing effect of physical activity on risk of cancer was shown for breast cancer, indicating a larger protective effect for physical activity after the age of 50 years than physical activity earlier in life (23, 57, 59). Inconsistent results were found in the 4 studies investigating the effect of physical activity at different age periods on the risk of lymphoma. Lu and colleagues and Lim and colleagues identified no association between physical activity at different life times and lymphoma risk (29, 39). Kabat and colleagues identified a significant association between having engaged in intense physical activity at ages 35 and 50 and non-Hodgkin lymphoma risk, whereas no significant association was found between intense physical activity at age 18 and non-Hodgkin lymphoma risk (37). Keegan and colleagues identified that strenuous physical activity in the year before diagnosis or interview, as well as sports team membership at ages 18 to 22 was significantly associated with Hodgkin lymphoma risk in young adult women, whereas no significant association was found between sports team membership in high school or strenuous physical activity throughout adult life and Hodgkin lymphoma risk (33). Since it was impossible to define 2 different timing groups in an unambiguous way, no subgroup analysis was conducted to investigate the timing effect of physical activity on risk of lymphoma.

Confounding factors

All included studies adjusted the outcome for age. Furthermore, all included studies considered gender either by adjusting for it (29, 31, 35) or by reporting results for men and women separately (28, 30, 32–34, 36–39). Other confounders that were taken into account in some but not all studies include education (7), smoking (6), BMI or weight (5), ethnicity (4), alcohol intake (3), and family history of lymphoma or hematopoietic cancer (3). Further, there were 17 factors taken into account in only 1 study (Table 1). As most studies only reported a maximal adjusted risk estimate and no minimal adjusted risk estimate, it was difficult to investigate the importance of the difference in adjustment for confounding factors. Item 18 of the quality score system questions the possibility of residual confounding. However, to assign a score on this item, it is important to know the potential confounders, or, in other words, the risk factors for lymphoma. Two well-established risk factors for lymphoma are immunosuppression and autoimmune disorders (60, 61). However, none of the included studies in this meta-analysis adjusted for these 2 confounders. Diet is also suggested to influence the risk of non-Hodgkin lymphoma. It has been shown that diary products, meat, and high fat intake are associated with an increased risk of non-Hodgkin lymphoma, whereas whole-grains and vegetables are inversely associated with risk of non-Hodgkin lymphoma (60, 62–64). Although 5 of the included studies adjusted for BMI or weight, none of the included studies adjusted for diet. As no included study adjusted for immunosuppression, autoimmune disorders, or diet, all included studies were assigned a score of 4 on the quality item about possibility of residual confounding. Differences in adjustment for confounding factors between the included studies probably did not play an important role in this meta-analysis, since every study adjusted for age and gender and none of the studies adjusted for immunosuppression, autoimmune disorders, or diet.

Biologic mechanisms

Several biologic mechanisms on how physical activity might reduce the risk of lymphoma were hypothesized in the literature. A first potential mechanism is the exercise-induced enhancement of the immune function by increasing the number and activity of macrophages, natural killer cells, lymphokine-activated killer cells, and regulating cytokines (32, 65). Indeed, there is evidence for elevated lymphoma incidence rates among subjects with immune dysregulation (30, 32, 33, 60, 65). Another possible mechanism is an exercise-induced decrease in insulin, glucose, and insulin-like growth factors (32, 33, 65), which is less favorable to the growth of tumor cells in general (17). Physical activity also prevents obesity and reduces the percentage of body fat (32, 65, 66), which serves as a storage depot for potential carcinogens. A positive association is observed between BMI and risk of lymphoma (60, 67). Finally, physical activity could reduce the risk of lymphoma by improving the antioxidant defense system and antiinflammatory effects (32, 33, 65).

Limitations

A potential limitation of this meta-analysis is the literature search. It is possible that not all published articles concerning this topic were selected. In an attempt to reduce this limitation, the reference lists of all selected articles were screened. A second possible limitation of this meta-analysis is a publication bias. However, most included studies reported no significant results, whereas in general significant findings are more likely to be published than nonsignificant findings. Therefore, publication bias does probably not play a major role in this meta-analysis. Third, a limitation of the literature is the use of self-reported instruments to assess physical activity, which have several disadvantages compared with objective assessments.

In conclusion, epidemiologic research indicates no significant influence of physical activity on risk of lymphoma. Interesting questions for future research include whether sedentary behavior is associated with the risk of lymphoma, whether there exists a dose–response effect of physical activity on risk of lymphoma, and whether the timing of physical activity (recent physical activity vs. lifetime physical activity) influences the association between physical activity and risk of lymphoma.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Authors' Contributions

Conception and design: N.V.H. Vermaete, P. Wolter, G.E.G. Verhoef, R. Gosselink

Development of methodology: N.V.H. Vermaete, G.E.G. Verhoef, B.J. Kollen, G. Kwakkel, R. Gosselink

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): G.E.G. Verhoef, B.J. Kollen, R. Gosselink

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): N.V.H. Vermaete, P. Wolter, G.E.G. Verhoef, G. Kwakkel, R. Gosselink

Writing, review, and/or revision of the manuscript: N.V.H. Vermaete, P. Wolter, G.E.G. Verhoef, B.J. Kollen, G. Kwakkel, R. Gosselink

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): N.V.H. Vermaete, L. Schepers, R. Gosselink

Study supervision: R. Gosselink

Grant Support

N. Vermaete is supported by a fellowship from the Research Foundation Flanders.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Received February 15, 2013.
  • Revision received April 16, 2013.
  • Accepted May 1, 2013.
  • ©2013 American Association for Cancer Research.

References

  1. 1.↵
    International Agency for Research on Cancer and Cancer Research UK. World Cancer Factsheets. 2012. London, United Kingdom, Cancer Research UK.
  2. 2.↵
    1. Ferlay J,
    2. Shin HR,
    3. Bray F,
    4. Forman D,
    5. Mathers C,
    6. Parkin DM
    . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. De Vita VT,
    2. Hellman S,
    3. Rosenberg S
    . Cancer: principles and practice of oncology. 7th ed. 2000.
  4. 4.↵
    1. Jemal A,
    2. Bray F,
    3. Center MM,
    4. Ferlay J,
    5. Ward E,
    6. Forman D
    . Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Devesa SS,
    2. Fears T
    . Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992;52(19 Suppl):5432s–40s.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Groves FD,
    2. Linet MS,
    3. Travis LB,
    4. Devesa SS
    . Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240–51.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Glaser SL
    . Recent incidence and secular trends in Hodgkin's disease and its histologic subtypes. J Chronic Dis 1986;39:789–98.
    OpenUrlPubMed
  8. 8.↵
    1. Wolff I,
    2. van Croonenborg JJ,
    3. Kemper HC,
    4. Kostense PJ,
    5. Twisk JW
    . The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999;9:1–12.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Astrup A
    . Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity. Public Health Nutr 2001;4(2B):499–515.
    OpenUrlPubMed
  10. 10.↵
    1. Gill JM,
    2. Cooper AR
    . Physical activity and prevention of type 2 diabetes mellitus. Sports Med 2008;38:807–24.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Denkinger MD,
    2. Nikolaus T,
    3. Denkinger C,
    4. Lukas A
    . Physical activity for the prevention of cognitive decline: current evidence from observational and controlled studies. Z Gerontol Geriatr 2012;45:11–6.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Borhani NO
    . Significance of physical activity for prevention and control of hypertension. J Hum Hypertens 1996;10 Suppl 2:S7–11.
    OpenUrlPubMed
  13. 13.↵
    1. Lakka TA,
    2. Laaksonen DE
    . Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:76–88.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Wannamethee SG,
    2. Shaper AG
    . Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med 2001;31:101–14.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Maltais F
    . Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies. Phys Sportsmed 2013;41:66–80.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Wolin KY,
    2. Yan Y,
    3. Colditz GA,
    4. Lee IM
    . Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 2009;100:611–6.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Friedenreich CM,
    2. Orenstein MR
    . Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002;132(11 Suppl):3456S–64S.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Monninkhof EM,
    2. Elias SG,
    3. Vlems FA,
    4. van dT I,
    5. Schuit AJ,
    6. Voskuil DW,
    7. et al.
    Physical activity and breast cancer: a systematic review. Epidemiology 2007;18:137–57.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Cust AE,
    2. Armstrong BK,
    3. Friedenreich CM,
    4. Slimani N,
    5. Bauman A
    . Physical activity and endometrial cancer risk: a review of the current evidence, biologic mechanisms and the quality of physical activity assessment methods. Cancer Causes Control 2007;18:243–58.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Tardon A,
    2. Lee WJ,
    3. Delgado-Rodriguez M,
    4. Dosemeci M,
    5. Albanes D,
    6. Hoover R,
    7. et al.
    Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 2005;16:389–97.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Liu Y,
    2. Hu F,
    3. Li D,
    4. Wang F,
    5. Zhu L,
    6. Chen W,
    7. et al.
    Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol 2011;60:1029–44.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Olsen CM,
    2. Bain CJ,
    3. Jordan SJ,
    4. Nagle CM,
    5. Green AC,
    6. Whiteman DC,
    7. et al.
    Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2007;16:2321–30.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Friedenreich CM,
    2. Neilson HK,
    3. Lynch BM
    . State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer 2010;46:2593–604.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Friedenreich CM,
    2. Cust AE
    . Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 2008;42:636–47.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Higgins JP,
    2. Thompson SG,
    3. Deeks JJ,
    4. Altman DG
    . Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60.
    OpenUrlFREE Full Text
  26. 26.↵
    1. Boyle T,
    2. Keegel T,
    3. Bull F,
    4. Heyworth J,
    5. Fritschi L
    . Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst 2012;104:1548–61.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    Review Manager (RevMan) [computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration; 2011.
  28. 28.↵
    1. Brownson RC,
    2. Chang JC,
    3. Davis JR,
    4. Smith CA
    . Physical activity on the job and cancer in Missouri. Am J Public Health 1991;81:639–42.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Lim U,
    2. Morton LM,
    3. Subar AF,
    4. Baris D,
    5. Stolzenberg-Solomon R,
    6. Leitzmann M,
    7. et al.
    Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007;166:697–708.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Zahm SH,
    2. Hoffman-Goetz L,
    3. Dosemeci M,
    4. Cantor KP,
    5. Blair A
    . Occupational physical activity and non-Hodgkin's lymphoma. Med Sci Sports Exerc 1999;31:566–71.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Cerhan JR,
    2. Bernstein L,
    3. Severson RK,
    4. Davis S,
    5. Colt JS,
    6. Blair A,
    7. et al.
    Anthropometrics, physical activity, related medical conditions, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2005;16:1203–14.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Pan SY,
    2. Mao Y,
    3. Ugnat AM
    . Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol 2005;162:1162–73.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Keegan TH,
    2. Glaser SL,
    3. Clarke CA,
    4. Dorfman RF,
    5. Mann RB,
    6. DiGiuseppe JA,
    7. et al.
    Body size, physical activity, and risk of Hodgkin's lymphoma in women. Cancer Epidemiol Biomarkers Prev 2006;15:1095–101.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Parent ME,
    2. Rousseau MC,
    3. El-Zein M,
    4. Latreille B,
    5. Desy M,
    6. Siemiatycki J
    . Occupational and recreational physical activity during adult life and the risk of cancer among men. Cancer Epidemiol 2011;35:151–9.
    OpenUrlPubMed
  35. 35.↵
    1. Kelly JL,
    2. Fredericksen ZS,
    3. Liebow M,
    4. Shanafelt TD,
    5. Thompson CA,
    6. Call TG,
    7. et al.
    The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol 2012;22:855–62.
    OpenUrlPubMed
  36. 36.↵
    1. van Veldhoven CM,
    2. Khan AE,
    3. Teucher B,
    4. Rohrmann S,
    5. Raaschou-Nielsen O,
    6. Tjonneland A,
    7. et al.
    Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC). Eur J Cancer 2011;47:748–60.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Kabat GC,
    2. Kim MY,
    3. Jean WW,
    4. Bea JW,
    5. Edlefsen KL,
    6. Adams-Campbell LL,
    7. et al.
    Anthropometric factors, physical activity, and risk of non-Hodgkin's lymphoma in the Women's Health Initiative. Cancer Epidemiol 2012;36:52–9.
    OpenUrlPubMed
  38. 38.↵
    1. Teras LR,
    2. Gapstur SM,
    3. Diver WR,
    4. Birmann BM,
    5. Patel AV
    . Recreational physical activity, leisure sitting time and risk of non-Hodgkin lymphoid neoplasms in the American Cancer Society Cancer Prevention Study II Cohort. Int J Cancer 2012;131:1912–20.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Lu Y,
    2. Prescott J,
    3. Sullivan-Halley J,
    4. Henderson KD,
    5. Ma H,
    6. Chang ET,
    7. et al.
    Body size, recreational physical activity, and B-cell non-Hodgkin lymphoma risk among women in the California teachers study. Am J Epidemiol 2009;170:1231–40.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Levels of evidence. Available from: http://www.cebm.net/?o=1025 2009.
  41. 41.↵
    1. Portney LG,
    2. Watkins MP
    . Epidemiology. Foundations of clinical research: applications to practice. 2nd ed. New Jersey: Prentice-Hall; 2000, p. 317–44.
  42. 42.↵
    1. Moore SC,
    2. Gierach GL,
    3. Schatzkin A,
    4. Matthews CE
    . Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 2010;103:933–8.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Samad AK,
    2. Taylor RS,
    3. Marshall T,
    4. Chapman MA
    . A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Dis 2005;7:204–13.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Harriss DJ,
    2. Atkinson G,
    3. Batterham A,
    4. George K,
    5. Cable NT,
    6. Reilly T,
    7. et al.
    Lifestyle factors and colorectal cancer risk (2): a systematic review and meta-analysis of associations with leisure-time physical activity. Colorectal Dis 2009;11:689–701.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Von EE,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gotzsche PC,
    6. Vandenbroucke JP
    . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–7.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Pitta F,
    2. Troosters T,
    3. Spruit MA,
    4. Decramer M,
    5. Gosselink R
    . Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005;86:1979–85.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Westerterp KR
    . Assessment of physical activity: a critical appraisal. Eur J Appl Physiol 2009;105:823–8.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. van Poppel MN,
    2. Chinapaw MJ,
    3. Mokkink LB,
    4. van MW,
    5. Terwee CB
    . Physical activity questionnaires for adults: a systematic review of measurement properties. Sports Med 2010;40:565–600.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Brownson RC,
    2. Zahm SH,
    3. Chang JC,
    4. Blair A
    . Occupational risk of colon cancer. An analysis by anatomic subsite. Am J Epidemiol 1989;130:675–87.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Garabrant DH,
    2. Peters JM,
    3. Mack TM,
    4. Bernstein L
    . Job activity and colon cancer risk. Am J Epidemiol 1984;119:1005–14.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    U.S. Department of Commerce. Standard Occupational Classification Manual. Washington, D.C.: U.S. Department of Commerce, Office of Federal Statistical Policy; 1977.
  52. 52.↵
    U.S. Department of Labor. Dictionary of Occupational Titles, 1977. Washington, D.C.: U.S. Department of Labor, Employment and Training Administration; 1977.
  53. 53.↵
    1. Paffenbarger RS Jr.,
    2. Lee IM,
    3. Wing AL
    . The influence of physical activity on the incidence of site-specific cancers in college alumni. Adv Exp Med Biol 1992;322:7–15.
    OpenUrlPubMed
  54. 54.↵
    1. Wareham NJ,
    2. Jakes RW,
    3. Rennie KL,
    4. Schuit J,
    5. Mitchell J,
    6. Hennings S,
    7. et al.
    Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407–13.
    OpenUrlCrossRefPubMed
  55. 55.↵
    Surgeon General's report on physical activity and health. From the centers for disease control and prevention. JAMA 1996;276:522.
    OpenUrlCrossRefPubMed
  56. 56.↵
    1. Thune I,
    2. Furberg AS
    . Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc 2001;33(6 Suppl):S530–S550.
    OpenUrlCrossRefPubMed
  57. 57.↵
    1. Pan SY,
    2. DesMeules M
    . Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 2009;472:191–215.
    OpenUrlCrossRefPubMed
  58. 58.↵
    1. Patel AV,
    2. Rodriguez C,
    3. Pavluck AL,
    4. Thun MJ,
    5. Calle EE
    . Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol 2006;163:709–16.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    1. Kruk J,
    2. Aboul-Enein HY
    . Physical activity in the prevention of cancer. Asian Pac J Cancer Prev 2006;7:11–21.
    OpenUrlPubMed
  60. 60.↵
    1. Zhang Y,
    2. Dai Y,
    3. Zheng T,
    4. Ma S
    . Risk factors of non-Hodgkin lymphoma. Expert Opin Med Diagn 2011;5:539–50.
    OpenUrlCrossRefPubMed
  61. 61.↵
    1. Aster JC
    . Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma. Available from: http://www.uptodate.com/contents/epidemiology-pathologic-features-and-diagnosis-of-classical-hodgkin-lymphoma. 2013;(21).
  62. 62.↵
    1. Chang ET,
    2. Smedby KE,
    3. Zhang SM,
    4. Hjalgrim H,
    5. Melbye M,
    6. Ost A,
    7. et al.
    Dietary factors and risk of non-Hodgkin lymphoma in men and women. Cancer Epidemiol Biomarkers Prev 2005;14:512–20.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Cross AJ,
    2. Lim U
    . The role of dietary factors in the epidemiology of non-Hodgkin's lymphoma. Leuk Lymphoma 2006;47:2477–87.
    OpenUrlCrossRefPubMed
  64. 64.↵
    1. Skibola CF
    . Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007;16:392–5.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    1. Pan SY,
    2. Morrison H
    . Physical activity and hematologic cancer prevention. Recent Results Cancer Res 2011;186:135–58.
    OpenUrlPubMed
  66. 66.↵
    1. Chiu BC,
    2. Soni L,
    3. Gapstur SM,
    4. Fought AJ,
    5. Evens AM,
    6. Weisenburger DD
    . Obesity and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2007;18:677–85.
    OpenUrlCrossRefPubMed
  67. 67.↵
    1. Patel AV,
    2. Diver WR,
    3. Teras LR,
    4. Birmann BM,
    5. Gapstur SM
    . Body mass index, height, and risk of lymphoid neoplasms in a large U.S. cohort. Leuk Lymphoma 2013;54:1221–7.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 22 (7)
July 2013
Volume 22, Issue 7
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Physical Activity and Risk of Lymphoma: A Meta-Analysis
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Physical Activity and Risk of Lymphoma: A Meta-Analysis
Nele V.H. Vermaete, Pascal Wolter, Gregor E.G. Verhoef, Boudewijn J. Kollen, Gert Kwakkel, Leen Schepers and Rik Gosselink
Cancer Epidemiol Biomarkers Prev July 1 2013 (22) (7) 1173-1184; DOI: 10.1158/1055-9965.EPI-13-0182

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Physical Activity and Risk of Lymphoma: A Meta-Analysis
Nele V.H. Vermaete, Pascal Wolter, Gregor E.G. Verhoef, Boudewijn J. Kollen, Gert Kwakkel, Leen Schepers and Rik Gosselink
Cancer Epidemiol Biomarkers Prev July 1 2013 (22) (7) 1173-1184; DOI: 10.1158/1055-9965.EPI-13-0182
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Epigenetic Alterations and Cervical Cancer Development
  • Lessons Learned from Setting Up a Prospective Study
  • Environmental Exposures and Non-Hodgkin Lymphoma
Show more Reviews
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement